Limits...
Androgen receptor functional analyses by high throughput imaging: determination of ligand, cell cycle, and mutation-specific effects.

Szafran AT, Szwarc M, Marcelli M, Mancini MA - PLoS ONE (2008)

Bottom Line: This was achieved by the selective analysis of cells expressing physiological levels of AR, important because minor over-expression resulted in elevated nuclear speckling and decreased transcriptional reporter gene activity.HT imaging of patient-derived AIS mutations demonstrated a proof-of-principle personalized medicine approach to rapidly identify ligands capable of restoring multiple AR functions.HT imaging-based multiplex screening will provide a rapid, systems-level analysis of compounds/RNAi that may differentially affect wild type AR or clinically relevant AR mutations.

View Article: PubMed Central - PubMed

Affiliation: Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA.

ABSTRACT

Background: Understanding how androgen receptor (AR) function is modulated by exposure to steroids, growth factors or small molecules can have important mechanistic implications for AR-related disease therapies (e.g., prostate cancer, androgen insensitivity syndrome, AIS), and in the analysis of environmental endocrine disruptors.

Methodology/principal findings: We report the development of a high throughput (HT) image-based assay that quantifies AR subcellular and subnuclear distribution, and transcriptional reporter gene activity on a cell-by-cell basis. Furthermore, simultaneous analysis of DNA content allowed determination of cell cycle position and permitted the analysis of cell cycle dependent changes in AR function in unsynchronized cell populations. Assay quality for EC50 coefficients of variation were 5-24%, with Z' values reaching 0.91. This was achieved by the selective analysis of cells expressing physiological levels of AR, important because minor over-expression resulted in elevated nuclear speckling and decreased transcriptional reporter gene activity. A small screen of AR-binding ligands, including known agonists, antagonists, and endocrine disruptors, demonstrated that nuclear translocation and nuclear "speckling" were linked with transcriptional output, and specific ligands were noted to differentially affect measurements for wild type versus mutant AR, suggesting differing mechanisms of action. HT imaging of patient-derived AIS mutations demonstrated a proof-of-principle personalized medicine approach to rapidly identify ligands capable of restoring multiple AR functions.

Conclusions/significance: HT imaging-based multiplex screening will provide a rapid, systems-level analysis of compounds/RNAi that may differentially affect wild type AR or clinically relevant AR mutations.

Show MeSH

Related in: MedlinePlus

Dose dependent effects measured in panel of AR antagonist compounds.The differential effects of various antagonist compounds on AR nuclear translocation, nuclear hyperspeckling, and transcriptional reporter gene activity in HeLa GFP-AR are plotted. Cells transfected with pARR-2PB-dsRED2skl reporter vector and maintained in 5% SD-FBS media for 12 hr. Cells were treated with indicated compound either alone (A, B, C) or with 10 nM R1881 (D, E, F) for 18 hr in 5%SD-FBS. Results normalized to negative (no treatment) and positive (R1881) controls. When possible, EC50 values were calculated using SigmaPlot 4-parameter curve fitting tool and presented±std. error (G). Data represents average of 8 experiments.
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC2572143&req=5

pone-0003605-g006: Dose dependent effects measured in panel of AR antagonist compounds.The differential effects of various antagonist compounds on AR nuclear translocation, nuclear hyperspeckling, and transcriptional reporter gene activity in HeLa GFP-AR are plotted. Cells transfected with pARR-2PB-dsRED2skl reporter vector and maintained in 5% SD-FBS media for 12 hr. Cells were treated with indicated compound either alone (A, B, C) or with 10 nM R1881 (D, E, F) for 18 hr in 5%SD-FBS. Results normalized to negative (no treatment) and positive (R1881) controls. When possible, EC50 values were calculated using SigmaPlot 4-parameter curve fitting tool and presented±std. error (G). Data represents average of 8 experiments.

Mentions: We and others have qualitatively shown that the anti-androgens o-hydroxyflutamide (OHF) and bicalutamide (CAS) can induce AR nuclear translocation, but not the hyperspeckling induced by AR agonists [1]–[3], [32], [33]. To quantitatively confirm these results with our assay system, we tested OHF, CAS and nilutamide (NIL) alone. The three compounds induced nuclear translocation at high concentrations, having EC50 values ∼600-fold higher than R1881 and maximum responses 70%–80% of R1881 (Fig. 6, Supplementary Table S6). As expected for these antagonists, no significant hyperspeckling or induction of transcription was observed.


Androgen receptor functional analyses by high throughput imaging: determination of ligand, cell cycle, and mutation-specific effects.

Szafran AT, Szwarc M, Marcelli M, Mancini MA - PLoS ONE (2008)

Dose dependent effects measured in panel of AR antagonist compounds.The differential effects of various antagonist compounds on AR nuclear translocation, nuclear hyperspeckling, and transcriptional reporter gene activity in HeLa GFP-AR are plotted. Cells transfected with pARR-2PB-dsRED2skl reporter vector and maintained in 5% SD-FBS media for 12 hr. Cells were treated with indicated compound either alone (A, B, C) or with 10 nM R1881 (D, E, F) for 18 hr in 5%SD-FBS. Results normalized to negative (no treatment) and positive (R1881) controls. When possible, EC50 values were calculated using SigmaPlot 4-parameter curve fitting tool and presented±std. error (G). Data represents average of 8 experiments.
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC2572143&req=5

pone-0003605-g006: Dose dependent effects measured in panel of AR antagonist compounds.The differential effects of various antagonist compounds on AR nuclear translocation, nuclear hyperspeckling, and transcriptional reporter gene activity in HeLa GFP-AR are plotted. Cells transfected with pARR-2PB-dsRED2skl reporter vector and maintained in 5% SD-FBS media for 12 hr. Cells were treated with indicated compound either alone (A, B, C) or with 10 nM R1881 (D, E, F) for 18 hr in 5%SD-FBS. Results normalized to negative (no treatment) and positive (R1881) controls. When possible, EC50 values were calculated using SigmaPlot 4-parameter curve fitting tool and presented±std. error (G). Data represents average of 8 experiments.
Mentions: We and others have qualitatively shown that the anti-androgens o-hydroxyflutamide (OHF) and bicalutamide (CAS) can induce AR nuclear translocation, but not the hyperspeckling induced by AR agonists [1]–[3], [32], [33]. To quantitatively confirm these results with our assay system, we tested OHF, CAS and nilutamide (NIL) alone. The three compounds induced nuclear translocation at high concentrations, having EC50 values ∼600-fold higher than R1881 and maximum responses 70%–80% of R1881 (Fig. 6, Supplementary Table S6). As expected for these antagonists, no significant hyperspeckling or induction of transcription was observed.

Bottom Line: This was achieved by the selective analysis of cells expressing physiological levels of AR, important because minor over-expression resulted in elevated nuclear speckling and decreased transcriptional reporter gene activity.HT imaging of patient-derived AIS mutations demonstrated a proof-of-principle personalized medicine approach to rapidly identify ligands capable of restoring multiple AR functions.HT imaging-based multiplex screening will provide a rapid, systems-level analysis of compounds/RNAi that may differentially affect wild type AR or clinically relevant AR mutations.

View Article: PubMed Central - PubMed

Affiliation: Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA.

ABSTRACT

Background: Understanding how androgen receptor (AR) function is modulated by exposure to steroids, growth factors or small molecules can have important mechanistic implications for AR-related disease therapies (e.g., prostate cancer, androgen insensitivity syndrome, AIS), and in the analysis of environmental endocrine disruptors.

Methodology/principal findings: We report the development of a high throughput (HT) image-based assay that quantifies AR subcellular and subnuclear distribution, and transcriptional reporter gene activity on a cell-by-cell basis. Furthermore, simultaneous analysis of DNA content allowed determination of cell cycle position and permitted the analysis of cell cycle dependent changes in AR function in unsynchronized cell populations. Assay quality for EC50 coefficients of variation were 5-24%, with Z' values reaching 0.91. This was achieved by the selective analysis of cells expressing physiological levels of AR, important because minor over-expression resulted in elevated nuclear speckling and decreased transcriptional reporter gene activity. A small screen of AR-binding ligands, including known agonists, antagonists, and endocrine disruptors, demonstrated that nuclear translocation and nuclear "speckling" were linked with transcriptional output, and specific ligands were noted to differentially affect measurements for wild type versus mutant AR, suggesting differing mechanisms of action. HT imaging of patient-derived AIS mutations demonstrated a proof-of-principle personalized medicine approach to rapidly identify ligands capable of restoring multiple AR functions.

Conclusions/significance: HT imaging-based multiplex screening will provide a rapid, systems-level analysis of compounds/RNAi that may differentially affect wild type AR or clinically relevant AR mutations.

Show MeSH
Related in: MedlinePlus